OBJECTIVE: To describe the electronic medical databases used in antiretroviral therapy (ART) programmes in lower-income countries and assess the measures such programmes employ to maintain and improve data quality and reduce the loss of patients to follow-up. METHODS: In 15 countries of Africa, South America and Asia, a survey was conducted from December 2006 to February 2007 on the use of electronic medical record systems in ART programmes. Patients enrolled in the sites at the time of the survey but not seen during the previous 12 months were considered lost to follow-up. The quality of the data was assessed by computing the percentage of missing key variables (age, sex, clinical stage of HIV infection, CD4+ lymphocyte count and year of ART initiation). Associations between site characteristics (such as number of staff members dedicated to data management), measures to reduce loss to follow-up (such as the presence of staff dedicated to tracing patients) and data quality and loss to follow-up were analysed using multivariate logit models. FINDINGS: Twenty-one sites that together provided ART to 50 060 patients were included (median number of patients per site: 1000; interquartile range, IQR: 72-19 320). Eighteen sites (86%) used an electronic database for medical record-keeping; 15 (83%) such sites relied on software intended for personal or small business use. The median percentage of missing data for key variables per site was 10.9% (IQR: 2.0-18.9%) and declined with training in data management (odds ratio, OR: 0.58; 95% confidence interval, CI: 0.37-0.90) and weekly hours spent by a clerk on the database per 100 patients on ART (OR: 0.95; 95% CI: 0.90-0.99). About 10 weekly hours per 100 patients on ART were required to reduce missing data for key variables to below 10%. The median percentage of patients lost to follow-up 1 year after starting ART was 8.5% (IQR: 4.2-19.7%). Strategies to reduce loss to follow-up included outreach teams, community-based organizations and checking death registry data. Implementation of all three strategies substantially reduced losses to follow-up (OR: 0.17; 95% CI: 0.15-0.20). CONCLUSION: The quality of the data collected and the retention of patients in ART treatment programmes are unsatisfactory for many sites involved in the scale-up of ART in resource-limited settings, mainly because of insufficient staff trained to manage data and trace patients lost to follow-up.
OBJECTIVE: To describe the electronic medical databases used in antiretroviral therapy (ART) programmes in lower-income countries and assess the measures such programmes employ to maintain and improve data quality and reduce the loss of patients to follow-up. METHODS: In 15 countries of Africa, South America and Asia, a survey was conducted from December 2006 to February 2007 on the use of electronic medical record systems in ART programmes. Patients enrolled in the sites at the time of the survey but not seen during the previous 12 months were considered lost to follow-up. The quality of the data was assessed by computing the percentage of missing key variables (age, sex, clinical stage of HIV infection, CD4+ lymphocyte count and year of ART initiation). Associations between site characteristics (such as number of staff members dedicated to data management), measures to reduce loss to follow-up (such as the presence of staff dedicated to tracing patients) and data quality and loss to follow-up were analysed using multivariate logit models. FINDINGS: Twenty-one sites that together provided ART to 50 060 patients were included (median number of patients per site: 1000; interquartile range, IQR: 72-19 320). Eighteen sites (86%) used an electronic database for medical record-keeping; 15 (83%) such sites relied on software intended for personal or small business use. The median percentage of missing data for key variables per site was 10.9% (IQR: 2.0-18.9%) and declined with training in data management (odds ratio, OR: 0.58; 95% confidence interval, CI: 0.37-0.90) and weekly hours spent by a clerk on the database per 100 patients on ART (OR: 0.95; 95% CI: 0.90-0.99). About 10 weekly hours per 100 patients on ART were required to reduce missing data for key variables to below 10%. The median percentage of patients lost to follow-up 1 year after starting ART was 8.5% (IQR: 4.2-19.7%). Strategies to reduce loss to follow-up included outreach teams, community-based organizations and checking death registry data. Implementation of all three strategies substantially reduced losses to follow-up (OR: 0.17; 95% CI: 0.15-0.20). CONCLUSION: The quality of the data collected and the retention of patients in ART treatment programmes are unsatisfactory for many sites involved in the scale-up of ART in resource-limited settings, mainly because of insufficient staff trained to manage data and trace patients lost to follow-up.
Authors: Hamish S F Fraser; Darius Jazayeri; Patrice Nevil; Yusuf Karacaoglu; Paul E Farmer; Evan Lyon; Mary Kay C Smith Fawzi; Fernet Leandre; Sharon S Choi; Joia S Mukherjee Journal: BMJ Date: 2004-11-13
Authors: François Dabis; Eric Balestre; Paula Braitstein; Paolo Miotti; W G Martin Brinkhof; Martin Schneider; Mauro Schechter; Christian Laurent; Andrew Boulle; Charles Kabugo; Gorana Capkun; Catherine Seyler; James McIntyre; Eduardo Sprinz; David Bangsberg; Stefan Van der Borght; Matthias Egger Journal: Int J Epidemiol Date: 2005-09-12 Impact factor: 7.196
Authors: Joseph K Rotich; Terry J Hannan; Faye E Smith; John Bii; Wilson W Odero; Nguyen Vu; Burke W Mamlin; Joseph J Mamlin; Robert M Einterz; William M Tierney Journal: J Am Med Inform Assoc Date: 2003-03-28 Impact factor: 4.497
Authors: Jeffrey S A Stringer; Isaac Zulu; Jens Levy; Elizabeth M Stringer; Albert Mwango; Benjamin H Chi; Vilepe Mtonga; Stewart Reid; Ronald A Cantrell; Marc Bulterys; Michael S Saag; Richard G Marlink; Alwyn Mwinga; Tedd V Ellerbrock; Moses Sinkala Journal: JAMA Date: 2006-08-16 Impact factor: 56.272
Authors: Burke W Mamlin; Paul G Biondich; Ben A Wolfe; Hamish Fraser; Darius Jazayeri; Christian Allen; Justin Miranda; William M Tierney Journal: AMIA Annu Symp Proc Date: 2006
Authors: Martin W G Brinkhof; François Dabis; Landon Myer; David R Bangsberg; Andrew Boulle; Denis Nash; Mauro Schechter; Christian Laurent; Olivia Keiser; Margaret May; Eduardo Sprinz; Matthias Egger; Xavier Anglaret Journal: Bull World Health Organ Date: 2008-07 Impact factor: 9.408
Authors: Olivia Keiser; Kathryn Anastos; Mauro Schechter; Eric Balestre; Landon Myer; Andrew Boulle; David Bangsberg; Hapsatou Touré; Paula Braitstein; Eduardo Sprinz; Denis Nash; Mina Hosseinipour; François Dabis; Margaret May; Martin W G Brinkhof; Matthias Egger Journal: Trop Med Int Health Date: 2008-03-27 Impact factor: 2.622
Authors: Paula Braitstein; Martin W G Brinkhof; François Dabis; Mauro Schechter; Andrew Boulle; Paolo Miotti; Robin Wood; Christian Laurent; Eduardo Sprinz; Catherine Seyler; David R Bangsberg; Eric Balestre; Jonathan A C Sterne; Margaret May; Matthias Egger Journal: Lancet Date: 2006-03-11 Impact factor: 79.321
Authors: A Spaar; C Graber; F Dabis; A Coutsoudis; L Bachmann; J McIntyre; M Schechter; H W Prozesky; S Tuboi; D Dickinson; N Kumarasamy; M Pujdades-Rodriquez; E Sprinz; H J Schilthuis; P Cahn; N Low; M Egger Journal: AIDS Care Date: 2010-06
Authors: Olivia Keiser; Hannock Tweya; Paula Braitstein; François Dabis; Patrick MacPhail; Andrew Boulle; Denis Nash; Robin Wood; Ruedi Lüthi; Martin W G Brinkhof; Mauro Schechter; Matthias Egger Journal: Trop Med Int Health Date: 2009-12-09 Impact factor: 2.622
Authors: Troy D Moon; Janeen R Burlison; Mohsin Sidat; Paulo Pires; Wilson Silva; Manuel Solis; Michele Rocha; Chiqui Arregui; Eric J Manders; Alfredo E Vergara; Sten H Vermund Journal: Retrovirology (Auckl) Date: 2010-04-23
Authors: Benjamin H Chi; Ronald A Cantrell; Albert Mwango; Andrew O Westfall; Wilbroad Mutale; Mohammed Limbada; Lloyd B Mulenga; Sten H Vermund; Jeffrey S A Stringer Journal: Am J Epidemiol Date: 2010-03-10 Impact factor: 4.897
Authors: Mattia C F Prosperi; Michal Rosen-Zvi; André Altmann; Maurizio Zazzi; Simona Di Giambenedetto; Rolf Kaiser; Eugen Schülter; Daniel Struck; Peter Sloot; David A van de Vijver; Anne-Mieke Vandamme; Anders Sönnerborg Journal: PLoS One Date: 2010-10-29 Impact factor: 3.240
Authors: Elena Losina; Hapsatou Touré; Lauren M Uhler; Xavier Anglaret; A David Paltiel; Eric Balestre; Rochelle P Walensky; Eugène Messou; Milton C Weinstein; François Dabis; Kenneth A Freedberg Journal: PLoS Med Date: 2009-10-27 Impact factor: 11.069